Genetic and clinical risk factors for anti-tuberculosis drug-induced liver injury: insights from a prospective cohort study in central Ethiopia

Purpose Drug-induced liver injury (DILI) is a relevant adverse event of tuberculosis treatment (TBT) especially in sub-Saharan Africa, but data remains limited. Genetic hepatic transport proteins polymorphisms (HTPP) are potential contributors. This study aimed to assess frequency and timing of DILI...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Klindt-Morgan, Caroline (VerfasserIn) , Fuchs, André (VerfasserIn) , Behnke, Kristina (VerfasserIn) , Dröge, Carola (VerfasserIn) , Eberhardt, Kirsten A. (VerfasserIn) , Orth, Hans Christian (VerfasserIn) , Pfäfflin, Frieder (VerfasserIn) , Schönfeld, Andreas Karl Rolf (VerfasserIn) , Nordmann, Tamara (VerfasserIn) , Mesfun, Million Getachew (VerfasserIn) , Keitel-Anselmino, Verena (VerfasserIn) , Lüdde, Tom (VerfasserIn) , Tufa, Tafese Beyene (VerfasserIn) , Jensen, Björn-Erik Ole (VerfasserIn) , Feldt, Torsten (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2025
In: Infection
Year: 2025, Jahrgang: 53, Heft: 6, Pages: 2833-2846
ISSN:1439-0973
DOI:10.1007/s15010-025-02632-7
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s15010-025-02632-7
Verlag, kostenfrei, Volltext: http://link.springer.com/article/10.1007/s15010-025-02632-7
Volltext
Verfasserangaben:Caroline Klindt, Andre Fuchs, Kristina Behnke, Carola Dröge, Kirsten Alexandra Eberhardt, Hans Christian Orth, Frieder Pfäfflin, Andreas Schönfeld, Tamara Nordmann, Million Getachew Mesfun, Verena Keitel, Tom Luedde, Tafese Beyene Tufa, Björn-Erik Ole Jensen, Torsten Feldt

MARC

LEADER 00000caa a2200000 c 4500
001 1938952472
003 DE-627
005 20251208113052.0
007 cr uuu---uuuuu
008 251021s2025 xx |||||o 00| ||eng c
024 7 |a 10.1007/s15010-025-02632-7  |2 doi 
035 |a (DE-627)1938952472 
035 |a (DE-599)KXP1938952472 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Klindt-Morgan, Caroline  |d 1986-  |e VerfasserIn  |0 (DE-588)1213271517  |0 (DE-627)1703790081  |4 aut 
245 1 0 |a Genetic and clinical risk factors for anti-tuberculosis drug-induced liver injury  |b insights from a prospective cohort study in central Ethiopia  |c Caroline Klindt, Andre Fuchs, Kristina Behnke, Carola Dröge, Kirsten Alexandra Eberhardt, Hans Christian Orth, Frieder Pfäfflin, Andreas Schönfeld, Tamara Nordmann, Million Getachew Mesfun, Verena Keitel, Tom Luedde, Tafese Beyene Tufa, Björn-Erik Ole Jensen, Torsten Feldt 
264 1 |c 2025 
300 |b Diagramme 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 4. September 2025 
500 |a Gesehen am 21.10.2025 
520 |a Purpose Drug-induced liver injury (DILI) is a relevant adverse event of tuberculosis treatment (TBT) especially in sub-Saharan Africa, but data remains limited. Genetic hepatic transport proteins polymorphisms (HTPP) are potential contributors. This study aimed to assess frequency and timing of DILI, identify risk factors, and explore the association of HTPP with DILI risk in Ethiopian TBT-patients. Methods In this prospective study, 424 confirmed tuberculosis patients in Ethiopian were recruited before initiation of TBT. Liver function tests were conducted during the first 8 weeks of treatment. Baseline evaluations included sociodemographic-, lifestyle- and clinical data including testing for viral co-infections, and HTPP as well as liver stiffness measurement by transient elastography (TE). Multivariable logistic regression, Cox proportional hazards models, and Fine and Gray competing risks analyses were employed for statistical analysis. Results Cumulative DILI incidence was 16.0% with 4.2% classified as severe occurring most commonly within the first two weeks. Urban residence (OR 2.00, 95% CI 1.03-3.84; HR 1.80, 95% CI 1.00-3.22) was associated with increased DILI risk. In the competing risks model, urban residence (sHR 6.26, p = 0.010) and pathologic TE (sHR 5.23, p = 0.005) predicted severe DILI. The investigated HTPPs were not significantly associated with DILI. Conclusion DILI is a common early complication of TBT in Ethiopian patients. Assessment of sociodemographic factors and TE before TBT may help identify high-risk individuals and offers a pragmatic approach for DILI management in resource-limited settings. 
700 1 |a Fuchs, André  |d 1980-  |e VerfasserIn  |0 (DE-588)14346955X  |0 (DE-627)646565680  |0 (DE-576)337231966  |4 aut 
700 1 |a Behnke, Kristina  |e VerfasserIn  |0 (DE-588)1064017444  |0 (DE-627)812856309  |0 (DE-576)423551698  |4 aut 
700 1 |a Dröge, Carola  |d 1984-  |e VerfasserIn  |0 (DE-588)1149161345  |0 (DE-627)1009427105  |0 (DE-576)496570056  |4 aut 
700 1 |a Eberhardt, Kirsten A.  |d 1984-  |e VerfasserIn  |0 (DE-588)142995800  |0 (DE-627)641424590  |0 (DE-576)334532973  |4 aut 
700 1 |a Orth, Hans Christian  |e VerfasserIn  |4 aut 
700 1 |a Pfäfflin, Frieder  |d 1973-  |e VerfasserIn  |0 (DE-588)123146283  |0 (DE-627)706180739  |0 (DE-576)184201373  |4 aut 
700 1 |a Schönfeld, Andreas Karl Rolf  |d 1982-  |e VerfasserIn  |0 (DE-588)139978437  |0 (DE-627)703525336  |0 (DE-576)313808457  |4 aut 
700 1 |a Nordmann, Tamara  |e VerfasserIn  |4 aut 
700 1 |a Mesfun, Million Getachew  |e VerfasserIn  |0 (DE-588)1220512257  |0 (DE-627)1737439034  |4 aut 
700 1 |a Keitel-Anselmino, Verena  |d 1976-  |e VerfasserIn  |0 (DE-588)129674745  |0 (DE-627)477115306  |0 (DE-576)297780247  |4 aut 
700 1 |a Lüdde, Tom  |d 1974-  |e VerfasserIn  |0 (DE-588)123687292  |0 (DE-627)082707960  |0 (DE-576)293827389  |4 aut 
700 1 |a Tufa, Tafese Beyene  |e VerfasserIn  |0 (DE-588)1225176468  |0 (DE-627)1744837821  |4 aut 
700 1 |a Jensen, Björn-Erik Ole  |d 1972-  |e VerfasserIn  |0 (DE-588)124260993  |0 (DE-627)085744611  |0 (DE-576)294092269  |4 aut 
700 1 |a Feldt, Torsten  |d 1968-  |e VerfasserIn  |0 (DE-588)130324639  |0 (DE-627)497981386  |0 (DE-576)29812775X  |4 aut 
773 0 8 |i Enthalten in  |t Infection  |d München : Urban & Vogel, 1973  |g 53(2025), 6, Seite 2833-2846  |h Online-Ressource  |w (DE-627)31236945X  |w (DE-600)2006315-5  |w (DE-576)090889487  |x 1439-0973  |7 nnas  |a Genetic and clinical risk factors for anti-tuberculosis drug-induced liver injury insights from a prospective cohort study in central Ethiopia 
773 1 8 |g volume:53  |g year:2025  |g number:6  |g pages:2833-2846  |a Genetic and clinical risk factors for anti-tuberculosis drug-induced liver injury insights from a prospective cohort study in central Ethiopia 
856 4 0 |u https://doi.org/10.1007/s15010-025-02632-7  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u http://link.springer.com/article/10.1007/s15010-025-02632-7  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20251021 
993 |a Article 
994 |a 2025 
998 |g 1213271517  |a Klindt-Morgan, Caroline  |m 1213271517:Klindt-Morgan, Caroline  |d 60000  |d 61100  |e 60000PK1213271517  |e 61100PK1213271517  |k 0/60000/  |k 1/60000/61100/  |p 1  |x j 
999 |a KXP-PPN1938952472  |e 479000340X 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"given":"Caroline","role":"aut","family":"Klindt-Morgan","display":"Klindt-Morgan, Caroline"},{"display":"Fuchs, André","family":"Fuchs","given":"André","role":"aut"},{"given":"Kristina","role":"aut","family":"Behnke","display":"Behnke, Kristina"},{"family":"Dröge","display":"Dröge, Carola","given":"Carola","role":"aut"},{"role":"aut","given":"Kirsten A.","family":"Eberhardt","display":"Eberhardt, Kirsten A."},{"display":"Orth, Hans Christian","family":"Orth","role":"aut","given":"Hans Christian"},{"given":"Frieder","role":"aut","family":"Pfäfflin","display":"Pfäfflin, Frieder"},{"display":"Schönfeld, Andreas Karl Rolf","family":"Schönfeld","given":"Andreas Karl Rolf","role":"aut"},{"role":"aut","given":"Tamara","display":"Nordmann, Tamara","family":"Nordmann"},{"role":"aut","given":"Million Getachew","display":"Mesfun, Million Getachew","family":"Mesfun"},{"display":"Keitel-Anselmino, Verena","family":"Keitel-Anselmino","given":"Verena","role":"aut"},{"display":"Lüdde, Tom","family":"Lüdde","role":"aut","given":"Tom"},{"given":"Tafese Beyene","role":"aut","display":"Tufa, Tafese Beyene","family":"Tufa"},{"given":"Björn-Erik Ole","role":"aut","display":"Jensen, Björn-Erik Ole","family":"Jensen"},{"role":"aut","given":"Torsten","family":"Feldt","display":"Feldt, Torsten"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Online veröffentlicht: 4. September 2025","Gesehen am 21.10.2025"],"origin":[{"dateIssuedDisp":"2025","dateIssuedKey":"2025"}],"title":[{"subtitle":"insights from a prospective cohort study in central Ethiopia","title_sort":"Genetic and clinical risk factors for anti-tuberculosis drug-induced liver injury","title":"Genetic and clinical risk factors for anti-tuberculosis drug-induced liver injury"}],"language":["eng"],"name":{"displayForm":["Caroline Klindt, Andre Fuchs, Kristina Behnke, Carola Dröge, Kirsten Alexandra Eberhardt, Hans Christian Orth, Frieder Pfäfflin, Andreas Schönfeld, Tamara Nordmann, Million Getachew Mesfun, Verena Keitel, Tom Luedde, Tafese Beyene Tufa, Björn-Erik Ole Jensen, Torsten Feldt"]},"physDesc":[{"noteIll":"Diagramme"}],"recId":"1938952472","relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["1.1973 -"],"recId":"31236945X","id":{"zdb":["2006315-5"],"eki":["31236945X"],"issn":["1439-0973"]},"disp":"Genetic and clinical risk factors for anti-tuberculosis drug-induced liver injury insights from a prospective cohort study in central EthiopiaInfection","note":["Gesehen am 05.12.05"],"origin":[{"dateIssuedDisp":"1973-","publisherPlace":"München ; Berlin ; Heidelberg","publisher":"Urban & Vogel ; Springer","dateIssuedKey":"1973"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title_sort":"Infection","title":"Infection"}],"part":{"volume":"53","issue":"6","year":"2025","pages":"2833-2846","text":"53(2025), 6, Seite 2833-2846"},"language":["eng"]}],"id":{"doi":["10.1007/s15010-025-02632-7"],"eki":["1938952472"]}} 
SRT |a KLINDTMORGGENETICAND2025